UCB (UCB)

Index:

BEL 20

  279.50
   
  • Change Today:
     5.80
  • 52 Week High:  279.50
  • 52 Week Low:  129.35
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 314,251
  • Market Cap:  53,105m
  • Beta: 2.16

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

UCB ShareCast News

No recent information was found.

UCB Newspaper Links

GSK gets emerging markets boost with UCB deal 24-Jan-2009 Telegraph
UCB confident on drug go-ahead 21-Aug-2007 The Scotsman
Fellner shuffles Acambis board 08-Mar-2007 Telegraph
Deal speeds drugs sector consolidation 26-Sep-2006 The Herald

UCB Tips & Analysis

No recent information was found.

UCB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   279.50
Change Today   5.80
% Change 2.12 %
52 Week High  279.50
52 Week Low  129.35
Volume 314,251
Shares Issued 190.00m
Market Cap  53,105m
Beta 2.16

What The Brokers Say

Strong Buy 6
Buy 11
Neutral 3
Sell 0
Strong Sell 1
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Feb-2026

Time Volume / Share Price
17:35 798 @  279.50
17:35 33 @  279.50
17:35 389 @  279.50
17:35 28 @  279.50
17:35 414 @  279.50

Top of Page